Download PDF
Pneumologie 2012; 66(08): 483-492
DOI: 10.1055/s-0032-1309811
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Amyloidose in der Pneumologie

Amyloidosis in Pneumology
L. Hagmeyer
1   Krankenhaus Bethanien gGmbH, Klinik für Pneumologie und Allergologie, Zentrum für Schlaf- und Beatmungsmedizin, Solingen
,
S. Stieglitz
1   Krankenhaus Bethanien gGmbH, Klinik für Pneumologie und Allergologie, Zentrum für Schlaf- und Beatmungsmedizin, Solingen
,
C. Röcken
2   Institut für Pathologie, Christian-Albrechts-Universität, Kiel
,
W. Randerath
1   Krankenhaus Bethanien gGmbH, Klinik für Pneumologie und Allergologie, Zentrum für Schlaf- und Beatmungsmedizin, Solingen
› Author Affiliations
Further Information

Publication History

eingereicht 31 January 2012

akzeptiert nach Revision18 April 2012

Publication Date:
12 June 2012 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Im pneumologischen Fachgebiet ist die Amyloidose eine seltene Krankheitsentität. Wahrscheinlich gibt es jedoch eine relevante Dunkelziffer an nicht diagnostizierten Fällen. Nach wie vor wird diese Erkrankung kaum ins differenzialdiagnostische Kalkül bei der Abklärung unklarer respiratorischer Beschwerden und bildmorphologischer Befunde mit einbezogen. Vielmehr handelt es sich bei den meisten Fällen um Zufallsdiagnosen, in der Regel erfolgt die Diagnosestellung erst durch den Pathologen anhand einer Gewebeprobe. Nur wenn die mannigfaltigen Manifestationsformen dem Kliniker bekannt sind, wird die Amyloidose im Einzelfall in der Differenzialdiagnose Berücksichtigung finden. Bei Verdacht auf das Vorliegen einer Amyloidose ist der zielführende diagnostische Schritt die Durchführung einer Gewebebiopsie. Wird die Diagnose in der Kongorotfärbung bestätigt, ist eine Subtypisierung des Amyloidproteins erforderlich, um nach möglichen behandelbaren Grunderkrankungen suchen zu können und die Therapie zu planen. Die Klassifikation der Amyloidosen erfolgt anhand des detektierten Amyloidproteins, klinisch werden hereditäre von erworbenen und lokale von generalisierten Formen abgegrenzt. Neben der Behandlung einer eventuell vorliegenden Grunderkrankung stehen für die generalisierten Amyloidosen systemische Therapien zur Verfügung. Lokale Amyloidosemanifestationen können oft gut mit spezifischen Lokalmaßnahmen behandelt werden. In dieser Übersichtsarbeit soll ein Überblick über die Pathophysiologie, die Klassifikation der Amyloidose-Unterformen, sowie deren Diagnostik und Therapie ermöglicht werden. Ein spezielles Augenmerk soll dabei auf die besonderen Manifestationen aus dem pneumologischen Fachgebiet und deren spezifische Therapiemöglichkeiten gelenkt werden.

Abstract

Amyloidosis is a rare disorder within the field of pneumology, however, it is estimated that there are a relevant number of unreported cases. In routine clinical practice, the disease is seldom considered in the diagnostic work-up of unclear respiratory symptoms and radiological findings. For amyloidosis to be considered as a differential diagnosis, the clinician must be aware of the broad variety of its clinical manifestations. In cases where amyloidosis is suspected, it is important to obtain an early tissue biopsy. If the diagnosis can be confirmed by Congo red staining, further subtyping of the amyloid protein is necessary in order to identify a treatable cause of the disease. The amyloidoses are classified according to the type of amyloid protein, with clinical subclassifications distinguishing hereditary from acquired forms and localised from generalised manifestations. Apart from causal therapy of the primary disease, the treatment of generalised amyloidosis includes specific systemic therapy. The majority of localised forms are treated with specific local interventions showing good long-term results. This review outlines the pathophysiology, classification, diagnostic pathways and therapeutic modalities in amyloidosis. Furthermore, typical manifestations of amyloidosis of the lung and the specific treatment options are discussed.

 

  • Literatur

  • 1 Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol 2000; 130: 88-98
    CrossrefPubMedGoogle Scholar
  • 2 Schonland SO, Moos M, Bochtler T et al. [Systemic light chain amyloidosis - molecular basis and clinical perspectives]. Deutsche medizinische Wochenschrift 2009; 134: 1949-1952
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Schonland SO, Bochtler T, Kristen AV et al. [Current diagnostic and therapy of light chain amyloidosis]. Pathologe 2009; 30: 205-211
    CrossrefPubMedGoogle Scholar
  • 4 Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Archives of internal medicine 1983; 143: 1549-1552
    CrossrefPubMedGoogle Scholar
  • 5 Duston MA, Skinner M, Shirahama T et al. Diagnosis of amyloidosis by abdominal fat aspiration. Analysis of four years' experience. The American journal of medicine 1987; 82: 412-414
    CrossrefPubMedGoogle Scholar
  • 6 Guidelines on the diagnosis and management of AL amyloidosis. Br J Haematol 2004; 125: 681-700
    CrossrefPubMedGoogle Scholar
  • 7 Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45-59
    PubMedGoogle Scholar
  • 8 Cohen AD, Comenzo RL. Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy. Hematology Am Soc Hematol Educ Program 2010; 2010: 287-294
    CrossrefPubMedGoogle Scholar
  • 9 Sipe JD, Benson MD, Buxbaum JN et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 2010; 17: 101-104
    CrossrefPubMedGoogle Scholar
  • 10 Rocken C, Ernst J, Hund E et al. Interdisciplinary guidelines for diagnosis and therapy of extracerebral amyloidosis: issued by the German Society of Amyloid Diseases e.V. Medizinische Klinik 2006; 101: 825-829
    CrossrefPubMedGoogle Scholar
  • 11 Eriksson M, Buttner J, Todorov T et al. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid. The American journal of surgical pathology 2009; 33: 58-65
    CrossrefPubMedGoogle Scholar
  • 12 Kyle RA, Therneau TM, Rajkumar SV et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564-569
    CrossrefPubMedGoogle Scholar
  • 13 Mikhael JR, Schuster SR, Jimenez-Zepeda VH et al. Cyclophosphamide-bortezomib-dexamethasone (CYBORD) produces rapid and complete hematological response in patients with AL amyloidosis. Blood 2012; Epub ahead of print
    PubMedGoogle Scholar
  • 14 Venner CP, Lane T, Foard D et al. Cyclophosphamide, bortezomib and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression free survival. Blood 2012; Epub ahead of print
    PubMedGoogle Scholar
  • 15 Akcay S, Akman B, Ozdemir H et al. Bronchiectasis-related amyloidosis as a cause of chronic renal failure. Renal failure 2002; 24: 815-823
    CrossrefPubMedGoogle Scholar
  • 16 Levasseur R, Le Goff C, Richer C et al. [AA amyloidosis complicating sarcoidosis]. Rev Med Interne 1999; 20: 168-170
    CrossrefPubMedGoogle Scholar
  • 17 Yonem O, Bayraktar Y. Secondary amyloidosis due to FMF. Hepatogastroenterology 2007; 54: 1061-1065
    PubMedGoogle Scholar
  • 18 Celli BR, Rubinow A, Cohen AS et al. Patterns of pulmonary involvement in systemic amyloidosis. Chest 1978; 74: 543-547
    CrossrefPubMedGoogle Scholar
  • 19 Smith RR, Hutchins GM, Moore GW et al. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid. The American journal of medicine 1979; 66: 96-104
    CrossrefPubMedGoogle Scholar
  • 20 Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Annals of Internal medicine 1996; 124: 407-413
    CrossrefPubMedGoogle Scholar
  • 21 Johnson WJ, Lie JT. Pulmonary hypertension and familial Mediterranean fever: a previously unrecognized association. Mayo Clinic proceedings. Mayo Clinic 1991; 66: 919-925
    CrossrefPubMedGoogle Scholar
  • 22 Livneh A, Langevitz P, Pras M. Pulmonary associations in familial Mediterranean fever. Curr Opin Pulm Med 1999; 5: 326-331
    CrossrefPubMedGoogle Scholar
  • 23 Kunze WP. Senile pulmonary amyloidosis. Pathol Res Pract 1979; 164: 413-422
    CrossrefPubMedGoogle Scholar
  • 24 Pitkanen P, Westermark P, Cornwell 3rd GG et al. Senile systemic amyloidosis. The American journal of pathology 1984; 117: 391-399
    PubMedGoogle Scholar
  • 25 Cordier JF, Loire R, Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest 1986; 90: 827-831
    CrossrefPubMedGoogle Scholar
  • 26 Berk JL, O'Regan A, Skinner M. Pulmonary and tracheobronchial amyloidosis. Semin Respir Crit Care Med 2002; 23: 155-165
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Fukatsu H, Miyoshi H, Ishiki K. Spontaneous resolution of multiple nodular pulmonary AA amyloidosis. Internal medicine 2010; 49: 2303-2307
    CrossrefPubMedGoogle Scholar
  • 28 Planes C, Kleinknecht D, Brauner M et al. Diffuse interstitial lung disease due to AA amyloidosis. Thorax 1992; 47: 323-324
    CrossrefPubMedGoogle Scholar
  • 29 Calatayud J, Candelas G, Gomez A et al. Nodular pulmonary amyloidosis in a patient with rheumatoid arthritis. Clinical rheumatology 2007; 26: 1797-1798
    CrossrefPubMedGoogle Scholar
  • 30 Kiuru S, Nieminen T, Partinen M. Obstructive sleep apnoea syndrome in hereditary gelsolin-related amyloidosis. Journal of sleep research 1999; 8: 143-149
    CrossrefPubMedGoogle Scholar
  • 31 Lesser BA, Leeper Jr KV, Conway W. Obstructive sleep apnea in amyloidosis treated with nasal continuous positive airway pressure. Archives of internal medicine 1988; 148: 2285-2287
    CrossrefPubMedGoogle Scholar
  • 32 Carbone JE, Barker D, Stauffer JL. Sleep apnea in amyloidosis. Chest 1985; 87: 401-403
    CrossrefPubMedGoogle Scholar
  • 33 Gallivan GJ, Gallivan HK. Laryngeal amyloidosis causing hoarseness and airway obstruction. J Voice 2010; 24: 235-239
    CrossrefPubMedGoogle Scholar
  • 34 Neuner GA, Badros AA, Meyer TK et al. Complete resolution of laryngeal amyloidosis with radiation treatment. Head Neck 2012; 34: 748-752
    CrossrefPubMedGoogle Scholar
  • 35 Ashe J, Borel CO, Hart G et al. Amyloid myopathy presenting with respiratory failure. Journal of neurology, neurosurgery, and psychiatry 1992; 55: 162-165
    CrossrefPubMedGoogle Scholar
  • 36 Berk JL, Wiesman JF, Skinner M et al. Diaphragm paralysis in primary systemic amyloidosis. Amyloid 2005; 12: 193-196
    CrossrefPubMedGoogle Scholar
  • 37 Santiago RM, Scharnhorst D, Ratkin G et al. Respiratory muscle weakness and ventilatory failure in AL amyloidosis with muscular pseudohypertrophy. The American journal of medicine 1987; 83: 175-178
    CrossrefPubMedGoogle Scholar
  • 38 Streeten EA, de la Monte SM, Kennedy TP. Amyloid infiltration of the diaphragm as a cause of respiratory failure. Chest 1986; 89: 760-762
    CrossrefPubMedGoogle Scholar
  • 39 Gagnon RF, Thirlweil M, Arzoumanian A et al. Systemic amyloidosis involving the diaphragm and acute massive hydrothorax during peritoneal dialysis. Clinical nephrology 2002; 57: 474-479
    PubMedGoogle Scholar
  • 40 Liu JY, Guo YJ, Zhou CK et al. Clinical and histopathological features of familial amyloidotic polyneuropathy with transthyretin Val30Ala in a Chinese family. Journal of the neurological sciences 2011; 304: 83-86
    CrossrefPubMedGoogle Scholar
  • 41 Erdem H, Simsek I, Pay S et al. Diffuse pulmonary amyloidosis that mimics interstitial lung disease in a patient with familial Mediterranean fever. J Clin Rheumatol 2006; 12: 34-36
    CrossrefPubMedGoogle Scholar
  • 42 Konietzko N. Pulmonary amyloidosis. Deutsche Medizinische Wochenschrift 2001; 126: 1369-1372
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Ware LB, Keith FM, Gordon RL et al. Lung transplantation for pulmonary amyloidosis: a case report. J Heart Lung Transplant 1998; 17: 1129-1132
    PubMedGoogle Scholar
  • 44 Roden AC, Aubry MC, Zhang K et al. Nodular senile pulmonary amyloidosis: a unique case confirmed by immunohistochemistry, mass spectrometry, and genetic study. Human pathology 2010; 41: 1040-1045
    CrossrefPubMedGoogle Scholar
  • 45 Rosen DJ, Stavropoulos C, Travis WD et al. Transdiaphragmatic amyloidoma. Ann Thorac Surg 2008; 86: 310-312
    CrossrefPubMedGoogle Scholar
  • 46 Gaurav K, Panda M. An uncommon cause of bilateral pulmonary nodules in a long-term smoker. J Gen Intern Med 2007; 22: 1617-1620
    CrossrefPubMedGoogle Scholar
  • 47 Gillmore JD, Hawkins PN. Amyloidosis and the respiratory tract. Thorax 1999; 54: 444-451
    CrossrefPubMedGoogle Scholar
  • 48 Chapman AD, Brown PA, Kerr KM. Right heart failure as the dominant clinical picture in a case of primary amyloidosis affecting the pulmonary vasculature. Scott Med J 1999; 44: 116-117
    PubMedGoogle Scholar
  • 49 Dingli D, Utz JP, Gertz MA. Pulmonary hypertension in patients with amyloidosis. Chest 2001; 120: 1735-1738
    CrossrefPubMedGoogle Scholar
  • 50 Eder L, Zisman D, Wolf R et al. Pulmonary hypertension and amyloidosis – an uncommon association: a case report and review of the literature. J Gen Intern Med 2007; 22: 416-419
    CrossrefPubMedGoogle Scholar
  • 51 Shiue ST, McNally DP. Pulmonary hypertension from prominent vascular involvement in diffuse amyloidosis. Archives of internal medicine 1988; 148: 687-689
    CrossrefPubMedGoogle Scholar
  • 52 Sterlacci W, Veits L, Moser P et al. Idiopathic systemic amyloidosis primarily affecting the lungs with fatal pulmonary haemorrhage due to vascular involvement. Pathol Oncol Res 2009; 15: 133-136
    CrossrefPubMedGoogle Scholar
  • 53 Shenin M, Xiong W, Naik M et al. Primary amyloidosis causing diffuse alveolar hemorrhage. J Clin Rheumatol 2010; 16: 175-177
    CrossrefPubMedGoogle Scholar
  • 54 Parambil JG, Savci CD, Tazelaar HD et al. Causes and presenting features of pulmonary infarctions in 43 cases identified by surgical lung biopsy. Chest 2005; 127: 1178-1183
    CrossrefPubMedGoogle Scholar
  • 55 Mansalis KA, Klein DA, Demartini SD et al. Pleural findings in a patient with persistent pulmonary effusions from systemic amyloidosis. Amyloid 2011; 18: 29-31
    PubMedGoogle Scholar
  • 56 Suzuki M, Betsuyaku T, Kojima T et al. Pleural involvement of dialysis-related amyloidosis. Internal medicine 2005; 44: 628-631
    CrossrefPubMedGoogle Scholar
  • 57 Araoka T, Takeoka H, Nishioka K et al. Successful management of refractory pleural effusion due to systemic immunoglobulin light chain amyloidosis by vincristine adriamycin dexamethasone chemotherapy: a case report. Journal of medical case reports 2010; 4: 322
    CrossrefPubMedGoogle Scholar
  • 58 Wirtz G, Andres E, Kessler R. [Thoracic impairment from familial Mediterranean fever: review of the literature and a case study]. Revue de pneumologie clinique 2009; 65: 313-317
    CrossrefPubMedGoogle Scholar
  • 59 Leleu O, Clarot C, Renaud H et al. [Amyloidosis and pleural calcification]. Revue des maladies respiratoires 2003; 20: 618-621
    PubMedGoogle Scholar
  • 60 Kieninger B, Eriksson M, Kandolf R et al. Amyloid in endomyocardial biopsies. Virchows Archiv : an international journal of pathology 2010; 456: 523-532
    CrossrefPubMedGoogle Scholar